Global Patent Index - EP 2026817 A1

EP 2026817 A1 2009-02-25 - USE OF DROSPIRENONE FOR PREVENTING HIGH BLOOD PRESSURE IN PREHYPERTENSIVE PATIENTS

Title (en)

USE OF DROSPIRENONE FOR PREVENTING HIGH BLOOD PRESSURE IN PREHYPERTENSIVE PATIENTS

Title (de)

VERWENDUNG VON DROSPIRENON ZUR PRÄVENTION VON BLUTHOCHDRUCK BEI PRÄHYPERTENSIVEN PATIENTEN

Title (fr)

UTILISATION DE LA DROSPIRÉNONE POUR LA PRÉVENTION DE L'HYPERTENSION ARTÉRIELLE CHEZ LES PATIENTS PRÉ-HYPERTENDUS

Publication

EP 2026817 A1 (EN)

Application

EP 07725456 A

Priority

  • EP 2007004556 W
  • US 80083406 P

Abstract (en)

[origin: WO2007131805A1] The present invention relates to the use of drospirenone for manufacture of a medicament for prevention of development of high blood pressure (> 140/90 mm Hg) in a patient who is predisposed to develop high blood pressure. The present invention further refers to methods of prevention of development of high blood pressure (= 140/90 mm Hg) in a patient who is predisposed to develop high blood pressure by administering drospirenone to a patient in need of such prevention.

IPC 8 full level (invention and additional information)

A61K 31/565 (2006.01); A61K 31/566 (2006.01); A61K 31/585 (2006.01); A61P 9/12 (2006.01)

CPC (invention and additional information)

A61K 31/565 (2013.01); A61K 31/566 (2013.01); A61K 31/585 (2013.01)

Combination set (CPC)

  1. A61K 31/565 + A61K 2300/00
  2. A61K 31/566 + A61K 2300/00
  3. A61K 31/585 + A61K 2300/00

Citation (search report)

See references of WO 2007131805A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK RS

EPO simple patent family

WO 2007131805 A1 20071122; AR 061006 A1 20080730; AU 2007251707 A1 20071122; BR PI0712072 A2 20120117; CA 2652483 A1 20071122; CL 2007001413 A1 20080808; CN 101472595 A 20090701; EP 2026817 A1 20090225; IL 195336 D0 20090803; JP 2009537470 A 20091029; KR 20090027209 A 20090316; MX 2008014647 A 20081127; RU 2008149412 A 20100627; US 2007275941 A1 20071129; UY 30358 A1 20080102

INPADOC legal status


2012-12-05 [18D] APPLICATION DEEMED TO BE WITHDRAWN

- Effective date: 20120606

2011-08-24 [RAP1] TRANSFER OF RIGHTS OF AN APPLICATION

- Owner name: BAYER PHARMA AKTIENGESELLSCHAFT

2009-06-24 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20090526

2009-02-25 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20081217

2009-02-25 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

2009-02-25 [AX] REQUEST FOR EXTENSION OF THE EUROPEAN PATENT TO:

- Countries: AL BA HR MK RS